{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:39Z","timestamp":1791247959024,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06272-z","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:14:44Z","timestamp":1783689284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-laboratory-based cardiovascular risk assessment:\u2009\u200910-year absolute risk, predicted heart age and intervention requirements in a Nigerian population"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-8401","authenticated-orcid":false,"given":"Oluseyi","family":"Adegoke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadamilola Omolara","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Akinkugbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Njideka Ulunma","family":"Okubadejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"6272_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736\u201388.","journal-title":"Lancet"},{"key":"6272_CR2","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HALE Collaborators","year":"2018","unstructured":"GBD 2017 DALYs and, Collaborators HALE. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1859\u2013922.","journal-title":"Lancet"},{"key":"6272_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jacc.2014.06.1151","volume":"64","author":"V Fuster","year":"2014","unstructured":"Fuster V. Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. J Am Coll Cardiol. 2014;64:520\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"6272_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937\u201352.","journal-title":"Lancet"},{"key":"6272_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761\u201375.","journal-title":"Lancet"},{"key":"6272_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019agostino","year":"2008","unstructured":"D\u2019agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117:743\u201353.","journal-title":"Circulation"},{"key":"6272_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-170","volume":"11","author":"TA Gaziano","year":"2013","unstructured":"Gaziano TA, Pandya A, Steyn K, Levitt N, Mollentze W, Joubert G, et al. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Med. 2013;11:1\u20131.","journal-title":"BMC Med"},{"key":"6272_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ypmed.2017.12.001","volume":"111","author":"JK Kariuki","year":"2018","unstructured":"Kariuki JK, Gona P, Leveille SG, Stuart-Shor EM, Hayman LL, Cromwell J. Cost-effectiveness of the non-laboratory based Framingham algorithm in primary prevention of cardiovascular disease: A simulated analysis of a cohort of African American adults. Prev Med. 2018;111:415\u201322.","journal-title":"Prev Med"},{"issue":"1","key":"6272_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40885-019-0112-1","volume":"25","author":"NU Okubadejo","year":"2019","unstructured":"Okubadejo NU, Ozoh OB, Ojo OO, Akinkugbe AO, Odeniyi IA, Adegoke O, et al. Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. Clin Hypertens. 2019;25(1):7.","journal-title":"Clin Hypertens"},{"key":"6272_CR10","doi-asserted-by":"crossref","unstructured":"Adegoke O, Odeniyi IA, Ojo OO, Ozoh OB, Akinkugbe AO, Okubadejo NU. Sociodemographic and lifestyle determinants of blood pressure in adult Nigerians. Int Health. 2025:ihaf048.","DOI":"10.1093\/inthealth\/ihaf048"},{"issue":"1","key":"6272_CR11","doi-asserted-by":"publisher","first-page":"e003499","DOI":"10.1136\/bmjgh-2020-003499","volume":"6","author":"RG Wagner","year":"2021","unstructured":"Wagner RG, Crowther NJ, Micklesfield LK, Boua PR, Nonterah EA, Mashinya, et al. Estimating the burden of cardiovascular risk in community dwellers over 40 years old in South Africa, Kenya, Burkina Faso and Ghana. BMJ global health. 2021;6(1):e003499.","journal-title":"BMJ global health"},{"key":"6272_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijcard.2017.11.082","volume":"254","author":"D Boateng","year":"2018","unstructured":"Boateng D, Agyemang C, Beune E, Meeks K, Smeeth L, Schulze MB, et al. Cardiovascular disease risk prediction in sub-Saharan African populations\u2014Comparative analysis of risk algorithms in the RODAM study. Int J Cardiol. 2018;254:310\u20135.","journal-title":"Int J Cardiol"},{"key":"6272_CR13","doi-asserted-by":"publisher","first-page":"101688","DOI":"10.1016\/j.eclinm.2022.101688","volume":"52","author":"WC Guzman-Vilca","year":"2022","unstructured":"Guzman-Vilca WC, Quispe-Villegas GA, Carrillo-Larco RM. Predicted heart age profile across 41 countries: A cross-sectional study of nationally representative surveys in six world regions. EClinicalMedicine. 2022;52:101688.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"6272_CR14","doi-asserted-by":"publisher","first-page":"16673","DOI":"10.1038\/s41598-017-16901-5","volume":"7","author":"D Appiah","year":"2017","unstructured":"Appiah D, Capistrant BD. Cardiovascular Disease Risk Assessment in the United States and Low- and Middle-Income Countries Using Predicted Heart\/Vascular Age. Sci Rep. 2017;7(1):16673.","journal-title":"Sci Rep"},{"key":"6272_CR15","unstructured":"WHO package of essential. noncommunicable (PEN) disease interventions for primary health care. WHO. https:\/\/www.who.int\/publications\/i\/item\/9789240009226. Accessed 5 Aug 2025."},{"key":"6272_CR16","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560\u201372.","journal-title":"JAMA"},{"key":"6272_CR17","unstructured":"World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva, World Health Organization, (Technical Report Series, No. 854) 329. (1995). https:\/\/www.who.int\/publications\/i\/item\/9241208546. Accessed 29 Jun 2026."},{"key":"6272_CR18","unstructured":"American Heart Association. American Heart Association recommendations for physical activity in adults and kids. https:\/\/www.heart.org\/en\/healthy-living\/fitness\/fitness-basics\/aharecs-for-physical-activity-in-adults. Accessed 26 Nov 2024."},{"key":"6272_CR19","unstructured":"World Health Organization. STEPwise approach to chronic disease risk factor surveillance. Geneva: World Health Organization. 2009. https:\/\/www.who.int\/chp\/steps\/reports\/en\/index.html. Accessed 18 Jun 2018."},{"issue":"9","key":"6272_CR20","doi-asserted-by":"publisher","first-page":"e0274242","DOI":"10.1371\/journal.pone.0274242","volume":"17","author":"ML Odland","year":"2022","unstructured":"Odland ML, Gassama K, Bockarie T, Wurie H, Ansumana R, Witham MD, et al. Cardiovascular disease risk profile and management among people 40 years of age and above in Bo, Sierra Leone: A cross-sectional study. PLoS ONE. 2022;17(9):e0274242.","journal-title":"PLoS ONE"},{"issue":"1","key":"6272_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s12889-022-13044-9","volume":"22","author":"OA Olubiyi","year":"2022","unstructured":"Olubiyi OA, Rotimi BF, Afolayan MA, Alatishe-Muhammad BW, Olubiyi OM, Balami AD. The ten-year risk of developing cardiovascular disease among public health workers in North-Central Nigeria using Framingham and atherogenic index of plasma risk scores. BMC Public Health. 2022;22(1):847.","journal-title":"BMC Public Health"},{"issue":"1","key":"6272_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32598\/CJHR.6.1.355.1","volume":"6","author":"A Esan","year":"2021","unstructured":"Esan A, Adeleye J, Adegoke Azeez T. Cardiovascular Risk Profile of Apparently Healthy Workers in a Tertiary Hospital in Nigeria. Casp J Health Res. 2021;6(1):1\u20138.","journal-title":"Casp J Health Res"},{"key":"6272_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01438-9","volume":"20","author":"OA Babatunde","year":"2020","unstructured":"Babatunde OA, Olarewaju SO, Adeomi AA, Akande JO, Bashorun A, Umeokonkwo CD, et al. 10-year risk for cardiovascular diseases using WHO prediction chart: findings from the civil servants in South-western Nigeria. BMC Cardiovasc Disord. 2020;20:1\u20130.","journal-title":"BMC Cardiovasc Disord"},{"key":"6272_CR24","first-page":"47","volume":"11","author":"SO Nduka","year":"2024","unstructured":"Nduka SO, Emeneka OC, Nduka IJ, Onunkwo JC. Cardiovascular risk screening: a 10-year prediction cross-sectional study in a Nigerian agrarian community. Pan Afr Med J. 2024;11:47.","journal-title":"Pan Afr Med J"},{"issue":"6","key":"6272_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.jhh.1001562","volume":"17","author":"O Akinboboye","year":"2003","unstructured":"Akinboboye O, Idris O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 2003;17(6):381\u20137.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"6272_CR26","doi-asserted-by":"publisher","first-page":"e0190441","DOI":"10.1371\/journal.pone.0190441","volume":"13","author":"C Diederichs","year":"2018","unstructured":"Diederichs C, Neuhauser H, R\u00fccker V, Busch MA, Keil U, Fitzgerald AP, et al. Predicted 10-year risk of cardiovascular mortality in the 40 to 69 year old general population without cardiovascular diseases in Germany. PLoS ONE. 2018;13(1):e0190441.","journal-title":"PLoS ONE"},{"key":"6272_CR27","doi-asserted-by":"publisher","first-page":"e64893","DOI":"10.2196\/64893","volume":"9","author":"S Scholes","year":"2025","unstructured":"Scholes S, Mindell JS, Toomse-Smith M, Cois A, Adjaye-Gbewonyo K. Estimating Trends in Cardiovascular Disease Risk for the EXPOSE (Explaining Population Trends in Cardiovascular Risk: A Comparative Analysis of Health Transitions in South Africa and England) Study: Repeated Cross-Sectional Study. JMIR Cardio. 2025;9:e64893.","journal-title":"JMIR Cardio"},{"issue":"1","key":"6272_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5334\/gh.403","volume":"15","author":"MF Yuyun","year":"2020","unstructured":"Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular diseases in sub-Saharan Africa compared to high-income countries: an epidemiological perspective. Global heart. 2020;15(1):15.","journal-title":"Global heart"},{"key":"6272_CR29","doi-asserted-by":"publisher","first-page":"619429","DOI":"10.3389\/fpubh.2021.619429","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Zhang X, Xu Y, Gao L, Ma Z, Sun Y, et al. Predicting the risk of hypertension based on several easy-to-collect risk factors: a machine learning method. Front Public Health. 2021;9:619429.","journal-title":"Front Public Health"},{"issue":"1","key":"6272_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hipert.2024.10.001","volume":"42","author":"VJ Vera-Ponce","year":"2025","unstructured":"Vera-Ponce VJ, Zuzunaga-Montoya FE, V\u00e1squez-Romero LEM, Loayza-Castro JA, De Carrillo CG. Vigil-Ventura. Prevalence, trends, and associated factors of isolated systolic, diastolic, and systolic-diastolic hypertension in Peru: a nine-year analysis of the Demographic and Family Health Survey. Hipertens Riesgo Vasc. 2025;42(1):18\u201328.","journal-title":"Hipertens Riesgo Vasc"},{"key":"6272_CR31","doi-asserted-by":"publisher","first-page":"e2024014","DOI":"10.4178\/epih.e2024014","volume":"46","author":"TT Bui","year":"2024","unstructured":"Bui TT, Nguyen THT, Lee J, Kim SY, Oh JK. Determinants of unhealthy living by gender, age group, and chronic health conditions across districts in Korea using the 2010\u20132017 Community Health Surveys. Epidemiol Health. 2024;46:e2024014.","journal-title":"Epidemiol Health"},{"issue":"1","key":"6272_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12872-025-04603-0","volume":"25","author":"RI Jalo","year":"2025","unstructured":"Jalo RI, Bamgboye EA, Salawu MM, Akinyemi JO, Uja U, Ogah OS, et al. Gender disparities in hypertension prevalence, awareness and healthcare seeking behaviour among young adults in Nigeria. BMC Cardiovasc Disord. 2025;25(1):151.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"6272_CR33","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.cpcardiol.2023.101604","volume":"48","author":"S Suman","year":"2023","unstructured":"Suman S, Pravalika J, Manjula P, Farooq U. Gender and CVD- Does It Really Matters? Curr Probl Cardiol. 2023;48(5):101604.","journal-title":"Curr Probl Cardiol"},{"key":"6272_CR34","first-page":"167","volume":"2","author":"R Oluyombo","year":"2015","unstructured":"Oluyombo R, Olamoyegun MA, Olaifa O, Iwuala SO, Babatunde OA. Cardiovascular risk factors in semi-urban communities in southwest Nigeria: Patterns and prevalence. J Epidemiol global health. 2015;2:167\u201374.","journal-title":"J Epidemiol global health"},{"issue":"5","key":"6272_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/jch.14220","volume":"23","author":"D Adeloye","year":"2021","unstructured":"Adeloye D, Owolabi EO, Ojji DB, Auta A, Dewan MT, Olanrewaju TO, et al. Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence. J Clin Hypertens. 2021;23(5):963\u201377.","journal-title":"J Clin Hypertens"},{"key":"6272_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13098-024-01315-x","volume":"16","author":"P Mohseni","year":"2024","unstructured":"Mohseni P, Khalili D, Djalalinia S, Mohseni H, Farzadfar F, Shafiee A, et al. The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey. Diabetol Metab Syndr. 2024;16:81.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"6272_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5334\/gh.1332","volume":"19","author":"AE Ojo","year":"2024","unstructured":"Ojo AE, Ojji DB, Grobbee DE, Huffman MD, Peters SAE. The Burden of Cardiovascular Disease Attributable to Hypertension in Nigeria: A Modelling Study Using Summary-Level Data. Glob Heart. 2024;19(1):50.","journal-title":"Glob Heart"},{"issue":"10226","key":"6272_CR38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795\u2013808.","journal-title":"Lancet"},{"issue":"21","key":"6272_CR39","doi-asserted-by":"publisher","first-page":"14571","DOI":"10.3390\/ijerph192114571","volume":"19","author":"MH Elnaem","year":"2022","unstructured":"Elnaem MH, Mosaad M, Abdelaziz DH, Mansour NO, Usman A, Elrggal ME, et al. Disparities in prevalence and barriers to hypertension control: a systematic review. Int J Environ Res Public Health. 2022;19(21):14571.","journal-title":"Int J Environ Res Public Health"},{"key":"6272_CR40","doi-asserted-by":"crossref","unstructured":"Chukwuonye II, Ohagwu KA, Ogah OS, John C, Oviasu E, Anyabolu EN et al. (2022) Prevalence of overweight and obesity in Nigeria: Systematic review and meta-analysis of population-based studies. PLOS Glob Public Health.2022;2(6):e0000515.","DOI":"10.1371\/journal.pgph.0000515"},{"issue":"1","key":"6272_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/njcp.njcp_1903_21","volume":"26","author":"MA Ramalan","year":"2023","unstructured":"Ramalan MA, Gezawa ID, Musa BM, Uloko AE, Fakhraddeen YM. Prevalence and trends of adult overweight and obesity in Nigeria\u2014a systematic review and meta-analysis. Niger J Clin Pract. 2023;26(1):1\u20135.","journal-title":"Niger J Clin Pract"},{"issue":"5","key":"6272_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000525792","volume":"15","author":"C Stival","year":"2022","unstructured":"Stival C, Lugo A, Odone A, Van den Brandt PA, Fernandez E, Tigova O, et al. Project Investigators. Prevalence and correlates of overweight and obesity in 12 European countries in 2017\u20132018. Obes Facts. 2022;15(5):655\u201365.","journal-title":"Obes Facts"},{"key":"6272_CR43","first-page":"18","volume":"4","author":"JB Ellecom","year":"2022","unstructured":"Ellecom JB, Shaw I, Adams GG. Obesity in Nigerian Adults and the Associated Cause and Impact on the Population. J Diabetes Res Reviews Rep. 2022;4:18\u20135.","journal-title":"J Diabetes Res Reviews Rep"},{"issue":"11","key":"6272_CR44","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/s41366-021-00908-0","volume":"45","author":"RA Mahumud","year":"2021","unstructured":"Mahumud RA, Sahle BW, Owusu-Addo E, Chen W, Morton RL, Renzaho AM. Association of dietary intake, physical activity, and sedentary behaviours with overweight and obesity among 282,213 adolescents in 89 low and middle income to high-income countries. Int J Obes. 2021;45(11):2404\u201318.","journal-title":"Int J Obes"},{"issue":"1","key":"6272_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40842-024-00209-1","volume":"10","author":"MA Olamoyegun","year":"2024","unstructured":"Olamoyegun MA, Alare K, Afolabi SA, Aderinto N, Adeyemi T. A systematic review and meta-analysis of the prevalence and risk factors of type 2 diabetes mellitus in Nigeria. Clin Diabetes Endocrinol. 2024;10(1):43.","journal-title":"Clin Diabetes Endocrinol"},{"key":"6272_CR46","unstructured":"Diabetes in Nigeria. (2024) \u2013 International Diabetes Federation. https:\/\/idf.org\/our-network\/regions-and-members\/africa\/members\/nigeria\/ Assessed 20 Jul 2025."},{"issue":"5","key":"6272_CR47","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s13410-022-01141-9","volume":"43","author":"B Ellahi","year":"2023","unstructured":"Ellahi B, Dikmen D, Seyhan-Erdo\u011fan B, Karabulut OF, Aitken A, Agbozo F, et al. Prevalence, risk factors, and self-awareness for hypertension and diabetes: rural\u2013urban and male\u2013female dimensions from a cross-sectional study in Ghana. Int J Diabetes Developing Ctries. 2023;43(5):694\u2013708.","journal-title":"Int J Diabetes Developing Ctries"},{"issue":"1","key":"6272_CR48","doi-asserted-by":"publisher","first-page":"2477941","DOI":"10.1080\/23288604.2025.2477941","volume":"11","author":"F Okonofua","year":"2025","unstructured":"Okonofua F, Ntoimo LF, Ogu R, Isikhuemen M. Public Policy and Health System Responses to Diabetes Mellitus in Nigeria: A Call for Reform. Health Syst Reform. 2025;11(1):2477941.","journal-title":"Health Syst Reform"},{"issue":"1","key":"6272_CR49","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1186\/s12889-019-8010-8","volume":"19","author":"D Adeloye","year":"2019","unstructured":"Adeloye D, Auta A, Fawibe A, Gadanya M, Ezeigwe N, Mpazanje RG, et al. Current prevalence pattern of tobacco smoking in Nigeria: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):1719.","journal-title":"BMC Public Health"},{"key":"6272_CR50","unstructured":"Status of tobacco use in the Region. World Health Organization. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/tobacco. Accessed\u00a020 Jul 2025."},{"issue":"7","key":"6272_CR51","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.21037\/jtd.2020.02.47","volume":"12","author":"G Gallucci","year":"2020","unstructured":"Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020;12(7):3866.","journal-title":"J Thorac Dis"},{"issue":"3","key":"6272_CR52","first-page":"e35966","volume":"15","author":"O Okorare","year":"2023","unstructured":"Okorare O, Evbayekha EO, Adabale OK, Daniel E, Ubokudum D, Olusiji SA, et al. Smoking cessation and benefits to cardiovascular health: a review of literature. Cureus. 2023;15(3):e35966.","journal-title":"Cureus"},{"issue":"4","key":"6272_CR53","first-page":"113","volume":"23","author":"BO Adeniyi","year":"2017","unstructured":"Adeniyi BO, Ilesanmi OS, Babasola OM, Awokola BI, Kareem AO, Obaseki D, et al. Knowledge of the health consequences of tobacco smoking among Nigerian smokers: A secondary analysis of the Global Tobacco Survey. Afr J Thorac Crit Care Med. 2017;23(4):113\u201321.","journal-title":"Afr J Thorac Crit Care Med"},{"issue":"1","key":"6272_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12872-018-0760-1","volume":"18","author":"C Bonner","year":"2018","unstructured":"Bonner C, Bell K, Jansen J, Glasziou P, Irwig L, Doust J, et al. Should heart age calculators be used alongside absolute cardiovascular disease risk assessment? BMC Cardiovasc Disord. 2018;18(1):19.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"6272_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12911-016-0342-z","volume":"16","author":"D Spiegelhalter","year":"2016","unstructured":"Spiegelhalter D. How old are you, really? Communicating chronic risk through \u2018effective age\u2019of your body and organs. BMC Med Inf Decis Mak. 2016;16(1):104.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"3","key":"6272_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/2047487313518479","volume":"22","author":"AA Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez AA, Aguilo A, Frontera M, Bennasar-Veny M, Campos I, Vicente-Herrero T, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. Eur J Prev Cardiol. 2015;22(3):389\u201396.","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"6272_CR57","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177\u2013232.","journal-title":"J Am Coll Cardiol"},{"issue":"654","key":"6272_CR58","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.3399\/bjgp16X687973","volume":"67","author":"C Crossan","year":"2017","unstructured":"Crossan C, Lord J, Ryan R, Nherera L, Marshall T. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen Pract. 2017;67(654):e67\u201377.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"6272_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12963-023-00301-1","volume":"21","author":"N Wilson","year":"2023","unstructured":"Wilson N, Cleghorn C, Nghiem N, Blakely T. Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data. Popul Health Metrics. 2023;21(1):1.","journal-title":"Popul Health Metrics"},{"key":"6272_CR60","doi-asserted-by":"crossref","unstructured":"The EUROASPIRE. investigators, Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions, Eur J Prev Cardiol. 2016; 23(18):2007\u201318.","DOI":"10.1177\/2047487316667784"},{"issue":"2","key":"6272_CR61","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30450-9","volume":"7","author":"S Basu","year":"2019","unstructured":"Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. Lancet Glob Health. 2019;7(2):e270\u201380.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"6272_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5334\/aogh.4131","volume":"89","author":"J Adeola","year":"2023","unstructured":"Adeola J, Obiezu F, Odukoya O, Igwilo U, Usinoma A, Bahiru E, et al. Barriers and Facilitators to Risk Reduction of Cardiovascular Disease in Hypertensive Patients in Nigeria. Ann Glob Health. 2023;89(1):88.","journal-title":"Ann Glob Health"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06272-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06272-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:05:11Z","timestamp":1791245111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06272-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6272"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06272-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Lagos University Teaching Hospital\u2019s Health Research Ethics Committee. In addition, permissions were obtained from the community leaders prior to study commencement. Written informed consent was obtained from the head of household and from each individual participant.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"874"}}